Adagene Inc.
Adagene Inc. (ADAG) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ADAG · as of Sep 30, 2025
Ownership Breakdown
18
Institutional Holders
▲ 3 vs Q2
$11.67M
Total Inst. Value
▼ $175,438 vs Q2
37.65M
Shares Outstanding
freeFloat 70.40%
5.91M
13F Shares Held
▼ 157,269 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ADAG largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
GENERAL ATLANTIC, L.P. pharmaceutical preparations | 3.78M | 10.04% | 10.04% | $7.53B | Nov 13, 2025 | ▼ 43.6K |
SC CHINA HOLDING LTD pharmaceutical preparations | 1.34M | 3.56% | 3.56% | $2.54B | Nov 14, 2025 | — held |
MILL CREEK CAPITAL ADVISORS, LLC pharmaceutical preparations | 199.6K | 52.96% | 52.96% | $397.22M | Nov 12, 2025 | — held |
BARCLAYS PLC pharmaceutical preparations | 186.9K | 49.59% | 49.59% | $414.93M | Mar 19, 2026 | ▲ 186.9K |
KAMUNTING STREET CAPITAL MANAGEMENT, L.P. pharmaceutical preparations | 126.0K | 33.44% | 33.44% | $251.00M | Nov 14, 2025 | — held |
MORGAN STANLEY pharmaceutical preparations | 82.8K | 21.96% | 21.96% | $164.68M | May 27, 2026 | ▲ 5.5K |
GORDIAN CAPITAL SINGAPORE PTE LTD pharmaceutical preparations | 48.3K | 12.83% | 12.83% | $96.20M | Nov 13, 2025 | ▲ 24.3K |
CITADEL ADVISORS LLC pharmaceutical preparations | 40.5K | 10.75% | 10.75% | $79.82M | Nov 14, 2025 | NEW |
FIFTH LANE CAPITAL, LP pharmaceutical preparations | 27.5K | 7.30% | 7.30% | $54.17M | Nov 12, 2025 | — held |
MAREX GROUP PLC pharmaceutical preparations | 23.4K | 6.21% | 6.21% | $46.60M | Nov 14, 2025 | ▼ 581 |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
3
Increased
+216.8K shares3
New Positions
first time holders5
Decreased
−49.1K shares1
Sold Out
fully exitedNet shares change (top 50)
+167.7K
+216.8K / −49.1K
Net new holders
+0
3 new / 1 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ADAG insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Adagene Inc. (ADAG) is primarily owned by institutional investors, who hold approximately 15.7% of total shares outstanding. Company insiders own approximately 29.60%, while retail and public investors account for the remaining 54.71%.
The largest institutional shareholder of Adagene Inc. is GENERAL ATLANTIC, L.P., holding approximately 3.78 million shares — equal to 10.04% of outstanding shares — as of September 30, 2025.
A total of 18 institutional investors currently hold ADAG stock, with a combined institutional value of approximately $11,666,767 as of the most recent 13F filing period.
Frequently asked questions
ADAG ownershipAdagene Inc. (ADAG) is primarily owned by institutional investors, who hold approximately 15.7% of shares. The largest shareholder is GENERAL ATLANTIC, L.P. with a 10.04% stake. Company insiders hold 29.60%. Data sourced from SEC Form 13F as of September 30, 2025.